BPKMCH | ANNUAL REPORT - 2018
DEPARTMENT OF MEDICAL ONCOLOGY
Introduction
Medical Oncology Department has been started its service since 1992 AD at B.P. Koirala Memorial Cancer
Hospital located in Chitwan. The responsibility of the department is to eliminate or to reduce the frequency
of cancer. It has been recognized to hold central posit on in clinical cancer act vit es of treatment method.
The discipline deals with cancer-related medical emergencies, disease natural courses, complicat on, and
pitalls. Introduct on and use of standard chemotherapy protocols for most of the cancer types have been
heavily carried out with considerat on of individualized management. Chemotherapy has resulted in curat ve
therapeut c intent for pat ents with hematologic malignancies and other types of solid tumors. It provides the
rat onale for integrat ng chemotherapy into combined modality programs with surgery and radiat on therapy
to provide the clinical benefit. Even medical oncologists do understand molecular basis of tumor progression
and exploit its behavior to kill maximum number of tumor cells through biological drugs.
The department has been commenced its service with 5 beds since 1992, Nowadays it has 102 inpat ent
beds which include 48 medical oncology beds, 24 hemato-oncology beds and, 30 pediatric unit beds and
daycare center has addit onal 24 beds. Furthermore, there is hospice center for terminally ill cancer pat ents.
Eight medical oncologists have been pract cing medical oncology for more than 12 years and have gained
considerable experience in the discipline they serve, two consultants and a Chinese hematologist provide
services on a regular basis throughout this t me.
Department has three units
Unit I and II medical oncology including hemato-oncology and pediatric oncology unit
Areas of expertise
I.
Solid tumors
II.
Hematopoiet c Malignancies
Head and neck cancer
Hodgkin’s and Non- Hodgkin’s lymphoma
Lung cancer
Plasma cell Dyscrasias
Gastrointest nal tract cancers
Chronic leukemia
Breast cancer
Myeloproliferat ve disorders
Gynecologic cancers
Acute leukemia & myelodysplast c syndromes
Germ cell tumors
III.
Complicat ons
Urinary tract cancers
Metabolic complicat ons
Neurological tumors
Thoracic complicat ons
Endocrine neoplasms
Renal compilat ons
Skin cancers
Neuromuscular complicat ons
Sarcomas
Haematologic complicat ons
Cancers in childhood
Bone and joint complicat ons
Miscellaneous neoplasms
Infect ous complicat ons
Metastases of unknown origin
Routine Activities
Daily two shifs OPD services
In pat ents care
Emergency management
Day care
Procedures like intrathecal (IT)
Bone marrow aspirat on
Pleural and ascit c tapping
Inst llat on of chemo drugs
Counseling
Targeted therapy Imat nib is to provide CML, Ph +ve ALL, and CD117 +ve GIST pat ents supported by Max
Foundat on USA.
Targeted therapy Sunit nib is to provide metastat c RCC, Glivec resistant GIST supported by Axios Health Care
Development, USA.
15
